BRANDY PRESTON: Open Payments
NPI 1417471103 · AURORA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 47 payments from 13 companies in 2025. Trend: 2023 $448 · 2024 $558 · 2025 $854
Food & beverage: $804Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $303 |
| PFIZER INC. | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Abbott Laboratories | 2 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Novo Nordisk Inc | 3 | $51 |
| Exact Sciences Corporation | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 2 | $30 |
Products named: VRAYLAR, CAPLYTA, Kerendia, UBRELVY, QULIPTA, ELIQUIS, FREESTYLE INSULINX, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
